查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1830970

深奧的測試市場

Esoteric Testing Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

預計深度測試市場將從 2024 年的 344 億美元擴大到 2031 年的 918.1 億美元，預計 2025 年至 2031 年的複合年成長率為 15.1%。

市場洞察與分析師觀點：特殊檢測涉及分析各種樣本中的稀有物質或分子，並非標準檢測程序的一部分。這個診斷環節需要訓練有素的專業人員和精密複雜的設備。此類檢測主要在專門的實驗室進行，樣本要么由醫療服務提供者轉介（住院檢測），要么由患者自行提交（門診檢測）。其中一些檢測採用放射免疫分析技術，該技術以成本高且耗時長而聞名。近年來，COVID-19 疫情顯著推動了特殊檢測市場的發展。 RT-PCR 檢測被廣泛用於定性檢測疑似 COVID-19 患者呼吸道樣本（透過鼻咽拭子或口咽拭子、痰液等採集）中的 SARS-CoV-2 RNA。

成長催化劑：慢性病發生率上升推動深奧檢測市場

美國癌症協會於2022年1月發布的《2022年癌症事實與數據》報告顯示，2022年美國新增癌症病例近190萬例，癌症相關死亡人數達609,360人。美國心臟協會2021年的一項研究預測，到2035年，美國將有超過1.3億成年人可能患有某種形式的心臟病。癌症和其他慢性病發生率的上升凸顯了準確診斷和治療的重要性。根據美國甲狀腺協會的估計，預計超過12%的美國人口在其一生中會患有甲狀腺疾病。由於不健康的飲食習慣和久坐不動的生活方式，激素紊亂的盛行率不斷上升，導致北美內分泌科檢測的數量增加。內分泌測試對於診斷荷爾蒙失調至關重要，包括與腦下垂體、甲狀腺、腎上腺、骨骼、類癌、神經內分泌和副甲狀腺腫瘤相關的荷爾蒙失調。

此外，慢性病發病率的上升以及針對特定治療領域的專用檢測試劑盒的推出，預計將在未來幾年推動特殊檢測市場的成長。世界衛生組織於2021年10月報告稱，到2030年，全球每6人中就有1人年齡在60歲或以上。預計到2050年，60歲及以上人口將從2020年的10億增加到14億。隨著老年人口更容易患上遺傳疾病和慢性疾病，預計在預測期內，特殊檢測的需求將大幅增加。

根據美國疾病管制與預防中心 (CDC) 的數據，2022 年 9 月報告了 420 例西尼羅河病毒病新病例，其中 65% 為神經侵襲性病例，35% 為非神經侵襲性病例。這些罕見疾病可以透過專門的傳染病檢測方法有效識別，從而進一步推動市場成長。

戰略洞察

報告細分和範圍：「深度檢測市場」按類型、技術和最終用戶進行分類。按類型分類，市場包括傳染病檢測、內分泌學檢測、腫瘤學檢測、毒理學檢測、免疫學檢測、神經病學檢測等。依技術分類，深度檢測市場分為化學發光免疫分析、酵素連結免疫吸附測定、質譜法、即時PCR、DNA定序、流式細胞儀等。依最終用戶分類，市場分為醫院和實驗室，以及獨立實驗室和參考實驗室。

細分分析：深層檢測市場按類型細分為傳染病檢測、內分泌學檢測、腫瘤學檢測、毒理學檢測、免疫學檢測、神經學檢測等。腫瘤學檢測領域在2022年佔據了最大的市場佔有率，而傳染病檢測領域預計在2022年至2030年期間的複合年成長率最高。

從技術面來看，深層檢測市場分為化學發光免疫分析、酵素連結免疫吸附分析、質譜法、即時PCR、DNA定序、流式細胞儀等。化學發光免疫分析領域在2022年佔據最大市場佔有率，而酵素連結免疫吸附分析領域預計在2022年至2030年期間達到18.7%的最高複合年成長率。

按最終用戶分類，深度測試市場分為醫院和實驗室，以及獨立實驗室和參考實驗室。醫院和實驗室在2022年佔據了更大的市場佔有率，預計2022年至2030年期間的複合年成長率將達到15.2%。

區域分析：全球深層測試市場分為亞太地區、歐洲、中東和非洲、北美以及南美和中美。 2022年，北美佔據最大市場佔有率，而預計2022年至2030年期間，亞太地區將在深層測試市場中實現最高的複合年成長率。

北美的深層檢測市場進一步細分為美國、加拿大和墨西哥。美國市場主要受慢性病盛行率上升和人們對早期發現疾病意識增強的推動。深層檢測通常用於分析標準檢測中未涵蓋的稀有和獨特物質。臨床實驗室需要專業知識才能進行這些檢測，因此大型商業實驗室將複雜的檢測外包給參考實驗室和深層檢測實驗室。在美國，進行深層檢測的知名實驗室包括Quest Diagnostics Incorporated、Mayo Medical Laboratories、ARUP Laboratories、Myriad Genetics、Genomic Health、Foundation Medicine和Laboratory Corporation of America。在美國，能夠進行這些專業檢測的實驗室數量正在增加。

美國內分泌學會2022年1月發表的文章指出，性腺功能低下是美國男性的普遍疾病，尤其在老年男性、肥胖男性以及2型糖尿病患者中更為普遍；據估計，45歲以上男性中有35%患有性腺功能低下，而2型糖尿病或肥胖症男性中有30%-50%患有性腺功能低下。此外，根據美國人口普查局的數據，65歲及以上男性的性腺功能低下發生率從2000年的約3500萬增加到2020年的約5500萬，預計到2050年將接近8700萬。這種疾病盛行率的上升與美國老齡人口的成長有關。此外，Statista報告稱，2020年美國有5,1642名成年人死於肝病，慢性肝病/肝硬化是當年美國第12大死因；酒精性肝硬化病例的增加是該疾病的重要危險因子。

因此，性腺功能低下、肝硬化和其他類似疾病的病例不斷增加，推動了全球深奧測試市場的成長。

深奧測試市場報告範圍行業發展和未來機會：深奧測試市場主要參與者的關鍵舉措包括：

2022年3月，沃特世公司推出了Xevo TQ Absolute系統，這是一款緊湊型桌上型串聯質譜儀。這款高靈敏度質譜儀可定量分析負離子化合物，靈敏度比上一代產品高出15倍，同時體積縮小了45%，耗電量和耗氣量降低了50%。

2021 年 2 月，Quest Diagnostics 與 Grail 合作進行 Galleri 多癌種血液檢測，計畫利用 Galleri 多重癌症早期檢測血液檢測提供靜脈穿刺服務。

競爭格局和主要公司：深奧測試市場的知名公司包括 Georgia Esoteric & Molecular Laboratory LLC、Laboratory Corp of America Holdings、Quest Diagnostics Inc.、National Medical Services Inc.、OPKO Health Inc.、ARUP Laboratories Inc.、bioMONTR Labs、Athena Esoterix LLC、Stanford Hospital & Clinicsies Inc.這些公司專注於引進新技術、增強現有產品並擴大其地理影響力，以滿足日益成長的全球消費者需求。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：深層測試市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：深奧測試市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：深奧測試市場 - 全球市場分析

  • 深奧測試 - 全球市場概覽
  • 深奧測試－全球市場及2030年預測

第7章：深奧測驗市場-收入分析-按類型，2020-2030

  • 概述
  • 傳染病檢測
  • 內分泌學檢查
  • 腫瘤學檢測
  • 毒理學測試
  • 免疫學檢測
  • 神經病學檢查
  • 其他

第 8 章：深層測試市場 - 收入分析 - 按技術，2020-2030 年

  • 概述
  • 即時PCR
  • 流式細胞儀
  • 質譜法
  • 酵素連結免疫吸附試驗
  • DNA定序
  • 化學發光免疫分析法
  • 其他技術

第 9 章：深奧測試市場 - 收入分析 - 按最終用戶，2020-2030 年

  • 概述
  • 醫院實驗室
  • 獨立和參考實驗室

第 10 章：深奧測驗市場 - 收入分析，2020-2030 年 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 12 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 13 章：深奧測試市場 - 主要公司簡介

  • Georgia Esoteric and Molecular Laboratory LLC
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • National Medical Services Inc
  • OPKO Health Inc
  • ARUP Laboratories Inc
  • bioMONTR Labs
  • Athena Esoterix LLC
  • Stanford Hospital and Clinics
  • Foundation Medicine Inc

第 14 章：附錄

簡介目錄
Product Code: TIPHE100001382

The esoteric testing market is anticipated to expand from US$ 34.40 billion in 2024 to US$ 91.81 billion by 2031, reflecting a projected CAGR of 15.1% from 2025 to 2031.

Market Insights and Analyst Perspective:Esoteric testing involves analyzing various samples for rare substances or molecules and is not part of standard testing procedures. This diagnostic segment necessitates highly trained professionals and sophisticated, intricate equipment. Such tests are primarily conducted in specialized laboratories, where samples are either referred by healthcare providers (inpatient testing) or submitted by patients themselves (outpatient testing). Some of these tests utilize the radioimmunoassay technique, which is known for being both costly and time-intensive. The COVID-19 pandemic has significantly boosted the esoteric testing market in recent years. The RT-PCR test is widely used for the qualitative detection of SARS-CoV-2 RNA from respiratory samples (collected via nasopharyngeal or oropharyngeal swabs, sputum, etc.) from individuals suspected of having COVID-19.

Growth Catalysts:Increasing Incidence of Chronic Diseases Fuels Esoteric Testing Market

The "Cancer Facts and Figures 2022" report from the American Cancer Society, published in January 2022, indicates that the US saw nearly 1.9 million new cancer cases and 609,360 cancer-related deaths in 2022. A study by the American Heart Association in 2021 projected that over 130 million adults in the US could be affected by some form of heart disease by 2035. The rising rates of cancer and other chronic diseases underscore the necessity for accurate diagnoses and treatments. According to estimates from the American Thyroid Association, more than 12% of the US population is expected to develop a thyroid condition during their lifetime. The increasing prevalence of hormonal disorders, driven by unhealthy eating habits and sedentary lifestyles, has led to a rise in endocrinology testing in North America. Endocrine tests are essential for diagnosing hormonal disorders, including those related to the pituitary, thyroid, adrenal, bone, carcinoid, neuroendocrine, and parathyroid tumors.

Moreover, the growing incidence of chronic diseases and the launch of specialized testing kits for specific therapeutic areas are expected to propel the esoteric testing market's growth in the coming years. The WHO reported in October 2021 that by 2030, 1 in 6 people globally will be aged 60 or older. The population aged 60 and above is projected to increase from 1 billion in 2020 to 1.4 billion by 2050. As the elderly population becomes more vulnerable to genetic and chronic diseases, the demand for esoteric tests is anticipated to rise significantly during the forecast period.

According to the CDC, in September 2022, there were 420 new cases of West Nile virus disease reported, with 65% classified as neuroinvasive and 35% as non-neuroinvasive. These rare diseases can be effectively identified through esoteric tests for infectious diseases, further driving market growth.

Strategic Insights

Report Segmentation and Scope:The "esoteric testing market" is categorized by type, technology, and end user. By type, the market includes infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. In terms of technology, the esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. For end users, the market is segmented into hospitals and laboratories, as well as independent and reference laboratories.

Segmental Analysis:The esoteric testing market is segmented by type into infectious disease testing, endocrinology testing, oncology testing, toxicology testing, immunology testing, neurology testing, and others. The oncology testing segment accounted for the largest market share in 2022, while the infectious disease testing segment is expected to exhibit the highest CAGR from 2022 to 2030.

In terms of technology, the esoteric testing market is divided into chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass spectrometry, real-time PCR, DNA sequencing, flow cytometry, and others. The chemiluminescence immunoassay segment held the largest market share in 2022, while the enzyme-linked immunosorbent assay segment is projected to achieve the highest CAGR of 18.7% from 2022 to 2030.

By end user, the esoteric testing market is categorized into hospitals and laboratories, and independent and reference laboratories. The hospitals and laboratories segment held a larger market share in 2022 and is expected to grow at a higher CAGR of 15.2% from 2022 to 2030.

Regional Analysis:The global esoteric testing market is divided into Asia Pacific, Europe, the Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest market share, while Asia Pacific is projected to register the highest CAGR in the esoteric testing market from 2022 to 2030.

The esoteric testing market in North America is further divided into the US, Canada, and Mexico. The US market is primarily driven by the increasing prevalence of chronic diseases and heightened awareness regarding early detection of medical conditions. Esoteric tests are typically conducted to analyze rare and unique substances not included in standard tests. Clinical laboratories require specialized expertise to perform these tests, leading large commercial laboratories to outsource complex tests to reference and esoteric testing laboratories. Notable labs conducting esoteric testing in the US include Quest Diagnostics Incorporated, Mayo Medical Laboratories, ARUP Laboratories, Myriad Genetics, Genomic Health, Foundation Medicine, and Laboratory Corporation of America. The number of laboratories capable of performing these specialized tests is on the rise in the country.

An article published by the Endocrine Society in January 2022 noted that hypogonadism is a prevalent condition among males in the US, particularly among older and obese men, as well as those with type 2 diabetes; it is estimated that 35% of men over 45 and 30-50% of men with type 2 diabetes or obesity have hypogonadism. Furthermore, according to the US Census Bureau, the incidence of hypogonadism in men aged 65 and older increased from approximately 35 million in 2000 to around 55 million by 2020, with projections of nearly 87 million by 2050. The rising prevalence of this condition correlates with the growing elderly population in the US. Additionally, Statista reported that 51,642 adults in the US died from liver disease in 2020, with chronic liver disease/cirrhosis ranked as the 12th leading cause of death in the US that year; the increase in alcoholic cirrhosis cases is a significant risk factor for this disease.

Consequently, the rising cases of hypogonadism, hepatic cirrhosis, and other similar conditions are propelling the growth of the global esoteric testing market.

Esoteric Testing Market Report Scope Industry Developments and Future Opportunities:Key initiatives by major players in the esoteric testing market include:

In March 2022, Waters Corporation introduced the Xevo TQ Absolute system, a compact benchtop tandem mass spectrometer. This highly sensitive mass spectrometer quantifies negatively ionizing compounds with up to 15-fold greater sensitivity than its predecessor, while being 45% smaller and consuming up to 50% less electricity and gas.

In February 2021, Quest Diagnostics partnered with Grail for its Galleri multicancer blood tests, planning to offer phlebotomy services utilizing the Galleri multicancer early-detection blood tests.

Competitive Landscape and Key Companies:Prominent companies in the esoteric testing market include Georgia Esoteric & Molecular Laboratory LLC, Laboratory Corp of America Holdings, Quest Diagnostics Inc., National Medical Services Inc., OPKO Health Inc., ARUP Laboratories Inc., bioMONTR Labs, Athena Esoterix LLC, Stanford Hospital & Clinics, and Foundation Medicine Inc. These companies are focused on introducing new technologies, enhancing existing products, and expanding their geographic presence to meet the increasing global consumer demand.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Esoteric Testing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Esoteric Testing Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Esoteric Testing Market - Global Market Analysis

  • 6.1 Esoteric Testing - Global Market Overview
  • 6.2 Esoteric Testing - Global Market and Forecast to 2030

7. Esoteric Testing Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Infectious Disease Testing
  • 7.3 Endocrinology Testing
  • 7.4 Oncology Testing
  • 7.5 Toxicology Testing
  • 7.6 Immunology Testing
  • 7.7 Neurology Testing
  • 7.8 Others

8. Esoteric Testing Market - Revenue Analysis (USD Million) - By Technology, 2020-2030

  • 8.1 Overview
  • 8.2 Real-Time PCR
  • 8.3 Flow Cytometry
  • 8.4 Mass Spectrometry
  • 8.5 Enzyme-Linked Immunosorbent Assay
  • 8.6 DNA Sequencing
  • 8.7 Chemiluminescence Immunoassay
  • 8.8 Other Technologies

9. Esoteric Testing Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospital Laboratories
  • 9.3 Independent and Reference Laboratories

10. Esoteric Testing Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Esoteric Testing Market Overview
    • 10.1.2 North America Esoteric Testing Market Revenue and Forecasts to 2030
    • 10.1.3 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Technology
    • 10.1.5 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Esoteric Testing Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Esoteric Testing Market
        • 10.1.6.1.1 United States Esoteric Testing Market, by Type
        • 10.1.6.1.2 United States Esoteric Testing Market, by Technology
        • 10.1.6.1.3 United States Esoteric Testing Market, by End User
      • 10.1.6.2 Canada Esoteric Testing Market
        • 10.1.6.2.1 Canada Esoteric Testing Market, by Type
        • 10.1.6.2.2 Canada Esoteric Testing Market, by Technology
        • 10.1.6.2.3 Canada Esoteric Testing Market, by End User
      • 10.1.6.3 Mexico Esoteric Testing Market
        • 10.1.6.3.1 Mexico Esoteric Testing Market, by Type
        • 10.1.6.3.2 Mexico Esoteric Testing Market, by Technology
        • 10.1.6.3.3 Mexico Esoteric Testing Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Esoteric Testing Market - Key Company Profiles

  • 13.1 Georgia Esoteric and Molecular Laboratory LLC
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Laboratory Corp of America Holdings
  • 13.3 Quest Diagnostics Inc
  • 13.4 National Medical Services Inc
  • 13.5 OPKO Health Inc
  • 13.6 ARUP Laboratories Inc
  • 13.7 bioMONTR Labs
  • 13.8 Athena Esoterix LLC
  • 13.9 Stanford Hospital and Clinics
  • 13.10 Foundation Medicine Inc

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud